IL-13Rα2-Targeting CAR T-Cell Therapy Improves Brain Cancer
City of Hope
Researchers were able to deliver the CAR-T cells directly into the tumor site and the cerebrospinal fluid
CAR T-cell therapy recipients with refractory lymphoma showed poorer treatment outcomes when treated with bendamustine
Multiple myeloma patients treated with CAR T-cell therapy showed similar survival outcomes regardless of race or ethnicity